The crisis in soaring drug prices has produced not merely a new class of public enemies to skewer — step forward, Martin Shkreli! — but the best evidence yet that the nation’s healthcare regulatory priorities are out of whack.
{iframe}http://www.latimes.com/business/hiltzik/la-fi-mh-the-fda-can-single-handedly-stop-20160105-column.html{/iframe}